rofecoxib has been researched along with Skin Neoplasms in 3 studies
Skin Neoplasms: Tumors or cancer of the SKIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Here we report on a patient with a metastatic melanoma of the leg who experienced a complete and sustained regression of skin metastases upon continuous single treatment with the cyclooxygenase-2 inhibitor rofecoxib." | 3.73 | Complete and long-lasting regression of disseminated multiple skin melanoma metastases under treatment with cyclooxygenase-2 inhibitor. ( Lejeune, FJ; Monnier, Y; Rüegg, C, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coras, B | 1 |
| Hafner, C | 1 |
| Reichle, A | 1 |
| Hohenleutner, U | 1 |
| Szeimies, RM | 1 |
| Landthaler, M | 1 |
| Vogt, T | 1 |
| Lejeune, FJ | 1 |
| Monnier, Y | 1 |
| Rüegg, C | 1 |
| Ziegler, J | 1 |
3 other studies available for rofecoxib and Skin Neoplasms
| Article | Year |
|---|---|
Antiangiogenic therapy with pioglitazone, rofecoxib, and trofosfamide in a patient with endemic kaposi sarcoma.
Topics: Adult; Angiogenesis Inhibitors; Cyclophosphamide; Drug Therapy, Combination; Endemic Diseases; Human | 2004 |
Complete and long-lasting regression of disseminated multiple skin melanoma metastases under treatment with cyclooxygenase-2 inhibitor.
Topics: Aged; Cyclooxygenase 2 Inhibitors; Female; Humans; Lactones; Melanoma; Remission Induction; Skin Neo | 2006 |
Early trials probe COX-2 inhibitors' cancer-fighting potential.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Clinical Trials as Topic; Colonic Neoplasms; Cyc | 1999 |